Personal information

No personal information available

Activities

Collapse all

Employment (1)

Future University in Egypt: Cairo, EG

2012-09-16 to present | Assistant lecturer (Pharmaceutical sciences and pharmaceutical industries )
Employment
Source: Self-asserted source
Shymaa Hatem

Works (5)

Functionalized chitosan nanoparticles for cutaneous delivery of a skin whitening agent: an approach to clinically augment the therapeutic efficacy for melasma treatment

Drug Delivery
2022 | Journal article
DOI: 10.1080/10717544.2022.2058652
EID:

2-s2.0-85127965925

Part of ISSN: 15210464 10717544
Contributors: Hatem, S.; Elkheshen, S.A.; Kamel, A.O.; Nasr, M.; Moftah, N.H.; Ragai, M.H.; Elezaby, R.S.; El Hoffy, N.M.
Source: Self-asserted source
Shymaa Hatem via Scopus - Elsevier

Background and different treatment modalities for melasma: Conventional and nanotechnology-based approaches

Journal of Drug Delivery Science and Technology
2020 | Journal article
DOI: 10.1016/j.jddst.2020.101984
EID:

2-s2.0-85089684914

Part of ISSN: 17732247
Contributors: Hatem, S.; El Hoffy, N.M.; Elezaby, R.S.; Nasr, M.; Kamel, A.O.; Elkheshen, S.A.
Source: Self-asserted source
Shymaa Hatem via Scopus - Elsevier

Clinical cosmeceutical repurposing of melatonin in androgenic alopecia using nanostructured lipid carriers prepared with antioxidant oils

Expert Opinion on Drug Delivery
2018 | Journal article
DOI: 10.1080/17425247.2018.1517740
EID:

2-s2.0-85053342749
Contributors: Hatem, S.; Nasr, M.; Moftah, N.H.; Ragai, M.H.; Geneidi, A.S.; Elkheshen, S.A.
Source: Self-asserted source
Shymaa Hatem via Scopus - Elsevier

Melatonin vitamin C-based nanovesicles for treatment of androgenic alopecia: Design, characterization and clinical appraisal

European Journal of Pharmaceutical Sciences
2018 | Journal article
DOI: 10.1016/j.ejps.2018.06.034
EID:

2-s2.0-85049562764
Contributors: Hatem, S.; Nasr, M.; Moftah, N.H.; Ragai, M.H.; Geneidi, A.S.; Elkheshen, S.A.
Source: Self-asserted source
Shymaa Hatem via Scopus - Elsevier

Recent advances in antioxidant cosmeceutical topical delivery

Current Drug Delivery
2018 | Journal article
DOI: 10.2174/1567201815666180214143551
EID:

2-s2.0-85050197358
Contributors: Hatem, S.; Nasr, M.; Elkheshen, S.A.; Geneidi, A.S.
Source: Self-asserted source
Shymaa Hatem via Scopus - Elsevier
How many people are using ORCID?